Q: How makes GEMÜ stand out in the healthcare supply chain and what are your main advantages against other companies?

MZ: GEMÜ is a German company with a global footprint. We manufacture valve, control, and measurement systems for liquids, vapors, and gases. Our core value lies in helping clients optimize their pharmaceutical, biotechnological, and industrial production processes. In essence, we are solution providers that drive efficiency and process improvement.

AS: Beyond just selling products, we deliver complete solutions. Our approach involves supporting clients from the design stage through to system integration, ensuring they have an end-to-end experience focused on quality, performance, and cost-efficiency.

Q: What opportunities has GEMÜ identified in the Mexican market?

MZ: Mexico is a strategic market, not only due to its robust pharmaceutical sector but also because of its expanding industrial base. It is a country with strong export capabilities and a consistent growth trajectory. Many global manufacturers are investing here, and we are proud to support them with cutting-edge fluid control technologies.

AS: We have had a direct presence in Mexico for over 10 years. From here, we provide access to the same advanced solutions offered in global markets but tailored to the unique demands of the Mexican industry.

Q: What challenges does GEMÜ face when expanding its footprint in Mexico?

AS: One of the main challenges is introducing new technologies in a market that often favors established, traditional solutions. Many companies are used to systems that may no longer be the most efficient or cost-effective. Convincing them to adopt innovative alternatives requires education, technical demonstrations, and a shift in mindset.

MZ: This is precisely why we are actively participating in trade events like ExpoFarma, to engage directly with the market, showcase our new platform, and demonstrate its value in real-world applications. We believe in building trust through results.

Q: Can you tell us more about the new technologies you are introducing?

MZ: Our new valve represents a complete redesign, from the body and pneumatic actuator to the integrated sensors and switch technology. It features improved flow characteristics and is significantly lighter, meaning we use less stainless steel, which is a cost-intensive material in the pharmaceutical sector. The result is a smarter, more efficient, and more affordable solution for our clients.

Q: What core message would you like your clients to take away about GEMÜ?

MZ: GEMÜ offers more than just components. We become true partners in your process, from the initial engineering phase to implementation and post-installation support. Our goal is to ensure our customers have a seamless, reliable, and forward-looking production experience.

AS: Our message is simple: open your processes to innovation. There is always a more efficient, sustainable, and productive way to operate and we are here to help you find it. 

Gemü Group is a global leader in valve, control, and regulation technology for liquids, vapors, and gases. It leads the world market in sterile process solutions and operates 25 subsidiaries worldwide.